8-KOther EventsExhibits & Filings

GE HealthCare Technologies Inc. 8-K Report, Corporate Update (Nov 8, 2024)

Filed November 8, 2024For Securities:GEHC

Summary

GE HealthCare Technologies Inc. (GEHC) announced the commencement and pricing of an underwritten offering of approximately 13.3 million shares of its common stock. Importantly, GE HealthCare itself will not be selling any shares and will not receive any proceeds from this offering. Instead, the shares are being offered by Morgan Stanley & Co. LLC, acting as a selling stockholder. Prior to this sale, GE Aerospace is expected to exchange these GEHC shares for indebtedness it holds with Morgan Stanley Bank, N.A. This transaction represents a debt-for-equity exchange involving GE Aerospace, with the resulting GEHC shares then being sold into the market by the designated selling stockholder. Investors should note that this offering primarily impacts the ownership structure of GEHC shares held by GE Aerospace and its affiliates, rather than directly raising capital for GE HealthCare.

Key Highlights

  • 1Underwritten offering of 13,281,302 GE HealthCare Technologies Inc. (GEHC) shares commenced and priced.
  • 2GE HealthCare Technologies Inc. is not selling any shares and will not receive proceeds from the offering.
  • 3GE Aerospace is expected to exchange GEHC shares for its indebtedness held by Morgan Stanley Bank, N.A. prior to the offering.
  • 4Morgan Stanley & Co. LLC is the selling stockholder, intending to sell the GEHC shares to underwriters.
  • 5The offering is conducted under an Underwriting Agreement dated November 7, 2024.
  • 6The transaction is structured as a debt-for-equity exchange related to GE Aerospace's holdings.

Frequently Asked Questions

No, GE HealthCare Technologies Inc. is not selling any shares and will not receive any proceeds from this underwritten offering. The shares being sold are part of an exchange involving GE Aerospace and a selling stockholder.

The GEHC shares are being sold by Morgan Stanley & Co. LLC, which is acting as a selling stockholder. These shares are expected to be acquired by Morgan Stanley & Co. LLC through a debt-for-equity exchange with GE Aerospace.

The debt-for-equity exchange is a preliminary step where GE Aerospace will exchange its holdings of GEHC shares for its own indebtedness held by Morgan Stanley Bank, N.A. This allows for the subsequent sale of those GEHC shares by the designated selling stockholder.

This specific offering does not directly impact GE HealthCare's financial position as it is not raising capital. It primarily affects the ownership and distribution of GEHC shares previously held by GE Aerospace.